Pharma News
AZ-3102 by Azafaros for Sandhoff Disease (Jatzkewitz-Pilz Syndrome): Likelihood of Approval
AZ-3102 is under clinical development by Azafaros and currently in Phase I for Sandhoff Disease (Jatzkewitz-Pilz Syndrome).
Source link
#AZ3102 #Azafaros #Sandhoff #Disease #JatzkewitzPilz #Syndrome #Likelihood #Approval